Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients

Julia Brunmair; Andrea Bileck; Doreen Schmidl; Gerhard Hagn; Samuel M. Meier-Menches; Nikolaus Hommer; Andreas Schlatter; Christopher Gerner; Gerhard Garhoefer

doi:10.1007/s13167-022-00272-7

Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients

Julia Brunmair, Andrea Bileck, Doreen Schmidl, Gerhard Hagn, Samuel M. Meier-Menches, Nikolaus Hommer, Andreas Schlatter, Christopher Gerner (Corresponding author), Gerhard Garhoefer (Corresponding author)

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	107-123
Number of pages	17
Journal	The EPMA journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1007/s13167-022-00272-7
Publication status	Published - Mar 2022

Austrian Fields of Science 2012

104026 Spectroscopy
106037 Proteomics
104002 Analytical chemistry

Keywords

Biomarker discovery
Individual metabolomics
Mass spectrometry
Predictive preventive personalised medicine (PPPM)
Sweat
Tear fluid analysis
Type 2 diabetes mellitus (T2DM)
CARNITINE METABOLITES
DIABETES-MELLITUS
URIC-ACID
SPECTROMETRY
PREVENTION
PREDICTION
BIOMARKERS
DISCOVERY
RISK
CARE

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s13167-022-00272-7Licence: CC BY 4.0

https://phaidra.univie.ac.at/o:1623972Licence: CC BY 4.0

Cite this

@article{2b961a33db414c7bb9ad282d6e6eb8fc,

title = "Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients",

keywords = "Biomarker discovery, Individual metabolomics, Mass spectrometry, Predictive preventive personalised medicine (PPPM), Sweat, Tear fluid analysis, Type 2 diabetes mellitus (T2DM), CARNITINE METABOLITES, DIABETES-MELLITUS, URIC-ACID, SPECTROMETRY, PREVENTION, PREDICTION, BIOMARKERS, DISCOVERY, RISK, CARE",

author = "Julia Brunmair and Andrea Bileck and Doreen Schmidl and Gerhard Hagn and Meier-Menches, {Samuel M.} and Nikolaus Hommer and Andreas Schlatter and Christopher Gerner and Gerhard Garhoefer",

note = "Accession Number: WOS:000749030500001 Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = mar,

doi = "10.1007/s13167-022-00272-7",

language = "English",

volume = "13",

pages = "107--123",

journal = "The EPMA journal",

issn = "1878-5077",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients

AU - Brunmair, Julia

AU - Bileck, Andrea

AU - Schmidl, Doreen

AU - Hagn, Gerhard

AU - Meier-Menches, Samuel M.

AU - Hommer, Nikolaus

AU - Schlatter, Andreas

AU - Gerner, Christopher

AU - Garhoefer, Gerhard

PY - 2022/3

Y1 - 2022/3

KW - Biomarker discovery

KW - Individual metabolomics

KW - Mass spectrometry

KW - Predictive preventive personalised medicine (PPPM)

KW - Sweat

KW - Tear fluid analysis

KW - Type 2 diabetes mellitus (T2DM)

KW - CARNITINE METABOLITES

KW - DIABETES-MELLITUS

KW - URIC-ACID

KW - SPECTROMETRY

KW - PREVENTION

KW - PREDICTION

KW - BIOMARKERS

KW - DISCOVERY

KW - RISK

KW - CARE

UR - http://www.scopus.com/inward/record.url?scp=85123822692&partnerID=8YFLogxK

U2 - 10.1007/s13167-022-00272-7

DO - 10.1007/s13167-022-00272-7

M3 - Article

C2 - 35265228

SN - 1878-5077

VL - 13

SP - 107

EP - 123

JO - The EPMA journal

JF - The EPMA journal

IS - 1

ER -

Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this